Pharmacological interventions for preventing delirium in the elderly

Area of Science:

• Geriatrics
• Pharmacology
• Critical Care Medicine

Background:

• Delirium is a frequent complication in elderly hospitalized patients, especially after surgery or during acute illness.
• It leads to adverse outcomes, including increased costs, dementia risk, and need for long-term care.
• Current prevention focuses on risk factor management and treating underlying conditions.

Purpose of the Study:

• To review the evidence for pharmacological agents in preventing delirium in hospitalized patients.
• To assess the efficacy and limitations of various drug classes for delirium prevention.

Main Methods:

• Systematic review of pharmacological interventions for delirium prevention.
• Analysis of clinical trial data for agents like antipsychotics, acetylcholinesterase inhibitors, melatonin, dexmedetomidine, and others.
• Evaluation of study heterogeneity, tolerability, and administration route limitations.

Main Results:

• Antipsychotics have limited preventive efficacy due to heterogeneity and side effects.
• Acetylcholinesterase inhibitors are ineffective for delirium prevention.
• Melatonin shows promise with a good safety profile; dexmedetomidine is useful in ICUs but limited elsewhere.
• Evidence for benzodiazepines, corticosteroids, statins, and gabapentin is lacking.

Conclusions:

• Current pharmacological strategies for delirium prevention show inconsistent efficacy.
• Melatonin and dexmedetomidine present potential but have limitations.
• Larger, well-designed, placebo-controlled trials are essential to establish effective pharmacological prevention methods.